Post-viral fatigue syndrome
From Wikipedia, the free encyclopedia
 |
It has been suggested that this article or section be merged with Chronic fatigue syndrome . (Discuss) |
| Post-viral fatigue syndrome | |
| Classification and external resources | |
| ICD-10 | G93.3 |
|---|---|
Post-viral fatigue syndrome (PVFS) is a condition or conditions characterized by fatigue following a viral infection. The term is not widely used, but the state of prolonged or severe fatigue after illness is not uncommon. Some people experience fatigue and related symptoms for months or years following a severe viral infection.[1] PVFS is considered one of many synonyms for chronic fatigue syndrome, a poorly understood collection of medically unexplained symptoms.[2]
Contents |
[edit] Classification
In the WHO's ICD-10, PVFS is listed as sub-category at G93.3 under category G93 'other disorders of the brain'.[3]. Listed under PVFS is benign myalgic encephalomyelitis.[4] The terms neuromyasthenia and chronic fatigue syndrome (CFS) also direct to sub-category G93.3 in the tabular list and alphabetic index of the ICD-10.[3][5].
Post-viral syndromes may also include: post-polio syndrome and possibly chronic mononucleosis or other severe chronic viral infections.
[edit] Signs and symptoms
The main symptoms of the syndrome are disabling fatigue, musculoskeletal pain, neurocognitive difficulties and mood disturbance.[1]
[edit] Risk factors
Some research indicates that that the chance of developing a post-viral fatigue syndrome is more strongly related to the severity of the infection rather than on demographic, psychological or microbiological characteristics.[1] Other research indicates the contrary and that doctor behaviour and patient attitudes were the best predictors.[6]
[edit] See also
[edit] References
- ^ a b c Hickie I, Davenport T, Wakefield D, et al. (2006). "Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study". BMJ 333 (7568): 575. doi:. PMID 16950834.
- ^ Cho HJ, Hotopf M, Wessely S. (2005). "The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis". Psychosomatic Medicine 67 (7568): 301-13. PMID 15784798.
- ^ a b International Classification of Diseases (Tabular List ed.), World Health Organization, 2007, http://www.who.int/classifications/apps/icd/icd10online/?gg90.htm+g93
- ^ Ramsay, Melvin A. (1986). Postviral Fatigue Syndrome. The saga of Royal Free disease. London: Gower. ISBN 0-906923-96-4.
- ^ ICD-10 International Statistical Classification of Diseases and Related Health Problems:, 3 (Alphabetical Index ed.), World Health Organization, 2006, p. 528, http://www.scribd.com/doc/7350978/ICD10-2006-Alphabetical-Index-Volume-3
- ^ Cope H, David A, Pelosi A, Mann A (September 24 1994), Predictors of chronic "postviral" fatigue, The Lancet, pp. 864–8, http://www.ncbi.nlm.nih.gov/pubmed/7916407
